{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A real-world survey to understand the perception of Dyslipidaemia, hypertriglyceridemia and Diabetes association and management in Indian population with high risk of cardiovascular disease (RED)

Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif {{--

--}} {{-- @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif --}}
  1. In your daily practice, how many newly diagnosed patients of T2DM are seen? *

  2. In your daily practice, how many patients do you see on an average with uncontrolled T2DM? *

  3. In your daily practice, how many patients do you see on an average with uncontrolled T2DM and critical co-morbidities? *

  4. In your daily practice, how many newly diagnosed patients of dyslipidaemia are seen? *

    5. {{--
  5. Which are the commonest co-morbidities seen in a newly diagnosed T2DM patient of Indian origin? (Can select more than one) *

    6. --}}
  6. Which are the commonest co-morbidities seen in a newly diagnosed T2DM patient of Indian origin? (Can select more than one) *

  7. In your daily practice what percentage of patients with T2DM have ASCVD? *

  8. In your daily practice what percentage of patients with Dyslipidaemia have ASCVD? *

  9. In your daily practice what percentage of patients have hypertriglyceridemia? *

  10. In your daily practice what percentage of patients with Diabetes have dyslipidaemia? *

  11. In your daily practice what percentage of patients with diabetes have hypertriglyceridemia? *

  12. What is your preferred HbA1c goal of therapy in patients with diabetes? *

  13. What is your target HbA1c and does it differ from patient to patient? Please explain with example? *
  14. What is your preferred LDL goal of therapy in patients with dyslipidaemia (Primary prevention population)? *

  15. What is your preferred LDL goal of therapy in patients with Diabetes? *

  16. What is your preferred LDL goal of therapy in patients with dyslipidaemia and ASCVD? *

  17. Level of triglycerides considered for diagnosis hypertriglyceridemia? *

  18. What is your preferred choice of therapy for hypertriglyceridemia? *

  19. What is your preferred choice of therapy as add-on for hypertriglyceridemia? *

  20. What factors determine the first-line therapy in your practice? *
  21. What factors determine the add-on therapy in your practice? *
  22. What is your preferred choice of therapy for hypertriglyceridemia with diabetes? *

  23. What is your preferred choice of therapy as add-on for hypertriglyceridemia with diabetes? *

  24. What is your preferred choice of therapy for hypertriglyceridemia with NAFLD/NASH? *

  25. What is your preferred choice of therapy as add-on for hypertriglyceridemia with NAFLD/NASH? *

  26. What factors determine the first-line therapy in your practice for hypertriglyceridemia with NAFLD/NASH?*
  27. What factors determine the add-on therapy in your practice for hypertriglyceridemia with NAFLD/NASH? *
  28. What factors determine the use of combination therapy *
  29. What steps can be taken to improve glycaemic control in Indian context *
  30. What steps can be taken to improve utilization of anti-dyslipidaemia therapy *
  31. Please share your suggestions on improving patient education for management of Diabetic dyslipidaemia *